Table 2.
Changes in laboratory index and tumor marker
| Item | Group | (n = 27) | Day 1 | Day 90 | P value |
|---|---|---|---|---|
| WBC (109/L) | A | 7.87 ± 4.90 | 8.22 ± 6.01 | P = 0.82 |
| B | 6.91 ± 2.96 | 6.94 ± 2.92 | P = 0.97 | |
| ALT (U/L) | A | 16.96 ± 9.04 | 18.40 ± 7.56 | P = 0.53 |
| B | 21.25 ± 11.29 | 21.72 ± 10.55 | P = 0.88 | |
| AST (U/L) | A | 25.33 ± 4.95 | 25.33 ± 8.98 | P = 0.99 |
| B | 28.54 ± 6.58 | 26.40 ± 7.58 | P = 0.30 | |
| Cr (μmol/L) | A | 73.59 ± 16.32 | 74.85 ± 20.98 | P = 0.81 |
| B | 63.12 ± 16.97 | 63.66 ± 16.89 | P = 0.91 | |
| CEA (ng/mL) | A | 36.90 ± 68.23 | 18.70 ± 33.77 | P = 0.02* |
| B | 37.42 ± 76.08 | 28.16 ± 69.80 | P = 0.66 | |
| NSE (ng/mL) | A | 33.04 ± 36.40 | 19.77 ± 6.93 | P = 0.04* |
| B | 27.45 ± 40.12 | 30.70 ± 23.2 | P = 0.57 |
*
P < 0.05 versus Group B.